Strategic Partnerships Medgene has active collaborations with major industry players such as Elanco Animal Health and has ties with Cornell University and Iowa State University. This presents an opportunity to position complementary vaccine platform solutions to their partners or to pursue co-development or distribution agreements leveraging existing relationships.

Platform Advantage The Prescription Platform emphasizes animal-origin free ingredients, a differentiator that can be leveraged to target quality-conscious veterinarians and producers seeking vaccine safety and traceability, expanding into premium livestock and companion-animal segments.

Expansion Targets Recent and ongoing vaccine development efforts for sheep, goats, cats, and potentially broader livestock indicate opportunities to upsell multi-species vaccine programs, cross-sell to mixed-practice clinics, and align with university-led research initiatives for field trials.

Market Readiness With revenue in the low millions and a focused animal health niche, Medgene is positioned for rapid scale through strategic distribution or CRO-type partnerships, especially leveraging Elanco’s channel and global reach to accelerate adoption.

Sales Momentum Key personnel moves such as hiring a sales and marketing manager and publicized collaborations suggest a growing sales engine; this momentum can be harnessed to drive targeted outreach to veterinarians, producers, and academic collaborators, emphasizing near-term product launches and trial programs.